EXANE DERIVATIVES - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$83,323,000
-56.0%
27,776
-7.9%
0.02%
-48.9%
Q3 2021$189,304,000
+34.1%
30,145
+25.7%
0.04%
+40.6%
Q2 2021$141,198,000
-50.5%
23,973
-46.8%
0.03%
-61.0%
Q1 2021$285,131,000
-1.2%
45,082
-12.1%
0.08%
-3.5%
Q4 2020$288,716,000
+10.5%
51,284
+14.3%
0.08%
+11.8%
Q3 2020$261,170,000
-17.4%
44,877
+2.3%
0.08%
-10.6%
Q2 2020$316,303,000
+27.1%
43,873
-17.5%
0.08%
+21.4%
Q1 2020$248,843,00053,1740.07%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders